Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema
Authors:
- 1 April 2016
- journal article
- research article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 164, 118-127.e2
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Intravitreal Aflibercept for Diabetic Macular EdemaOphthalmology, 2015
- Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular EdemaNew England Journal of Medicine, 2015
- Intravitreal Aflibercept for Diabetic Macular EdemaOphthalmology, 2014
- A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular EdemaArchives of Ophthalmology (1950), 2012
- Ranibizumab for Diabetic Macular EdemaOphthalmology, 2012
- Global Prevalence and Major Risk Factors of Diabetic RetinopathyDiabetes Care, 2012
- Managing diabetic macular edema: The leading cause of diabetes blindnessWorld Journal of Diabetes, 2011
- Global Prevalence of DiabetesDiabetes Care, 2004
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- Photocoagulation for Diabetic Macular EdemaArchives of Ophthalmology (1950), 1985